ELMD: Strong growth, high margins, and new clinical guidelines drive expansion in a $3B US market
A single-product med tech company with strong financials and no debt is leveraging new clinical guidelines, increased disease awareness, and a vertically integrated model to expand in a $3 billion US market. Clinical outcomes and high margins support ongoing growth and investment.Based on Electrome…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.